Skip to main content
Quan Nguyen, MD, Ophthalmology, Palo Alto, CA, Stanford Health Care

QuanDongNguyenMD

Ophthalmology Palo Alto, CA

Retinal Disease, Uveitis

Professor of Ophthalmology, Director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University Former Director and Chairman, Truhlsen Eye Institute, University of Nebraska Medical Center Former Assistant Dean for Translational Research, University of Nebraska Medical Center

Dr. Nguyen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nguyen's full profile

Already have an account?

  • Office

    Byers Eye Institute at Stanford
    2452 Watson Court
    Palo Alto, CA 94303
    Phone+1 650-723-6995
    Fax+1 650-565-8297
  • Is this information wrong?

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1994 - 1997
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2024
  • CA State Medical License
    CA State Medical License 2016 - 2024
  • NE State Medical License
    NE State Medical License 2013 - 2018
  • MD State Medical License
    MD State Medical License 1998 - 2013
  • DC State Medical License
    DC State Medical License 1998 - 2002
  • VA State Medical License
    VA State Medical License 1998 - 2002
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Blue Light Versus Green Light Fundus Autofluorescence in Normal Subjects and in Patients with Retinochoroidopathy Secondary to Retinal and Uveitic Diseases  
    Quan Nguyen, MD, Springer Open
  • Diurnal Variation of Choriocapillaris Vessel Flow Density in Normal Subjects Measured Using Optical Coherence Tomography Angiography  
    Salman Sarwar, Quan Dong Nguyen, Aniruddha Agarwal, BioMed Central

Authored Content

  • Brolucizumab: Evolution Through Preclinical and Clinical Studies, and the Implications for the Management of nAMDJanuary 2020

Press Mentions

  • LumiThera Announces Sustained Vision Improvement for 24 Months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data
    LumiThera Announces Sustained Vision Improvement for 24 Months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial DataMarch 15th, 2023
  • Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to Discuss LBS-008 Interim Data
    Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to Discuss LBS-008 Interim DataOctober 20th, 2022
  • Treatment Outcomes of Focal Laser Consolidation During Chemoreduction for Group B Retinoblastoma
    Treatment Outcomes of Focal Laser Consolidation During Chemoreduction for Group B RetinoblastomaMay 26th, 2020
  • Join now to see all

Grant Support

  • Mechanisms Of Glucose ToxicityNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Novel Assessment Of Early Changes In Diabetic RetinopathyNational Eye Institute2008–2010
  • Supplemental Oxygen For Hypoxia-Related Retinal DeseasesNational Eye Institute2001–2005

Professional Memberships

Hospital Affiliations